Kingdon Capital Management, L.L.C. Intercept Pharmaceuticals, Inc. Transaction History
Kingdon Capital Management, L.L.C.
- $834 Million
- Q3 2024
A detailed history of Kingdon Capital Management, L.L.C. transactions in Intercept Pharmaceuticals, Inc. stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 100,000 shares of ICPT stock, worth $0. This represents 1.5% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$0% of portfolio
1.5%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ICPT
# of Institutions
6Shares Held
1.04MCall Options Held
30KPut Options Held
5.9KAbout INTERCEPT PHARMACEUTICALS, INC.
- Ticker ICPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,127,400
- Description
- Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...